RIVAROXABAN
Clinical Indication
Treatment and secondary prevention of DVT and PE
Comments
In line with NICE TA 261 or NICE TA 287
Date of classification
September 2012
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .